Atividade física de intensidade moderada e moderada-vigorosa associada a desfechos clínicos e funcionais em indivíduos com doença pulmonar obstrutiva crônica
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Chronic obstructive pulmonary disease (COPD) causes several morbidities and high
mortality. Due to systemic changes and symptoms, physical inactivity is common in people
with COPD. The World Health Organization (WHO) recommends moderate physical activity
(AFM) and/or vigorous physical activity (PAV) for the health of the general population, and
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines recommend
the regular practice of physical activity (PA) for people with COPD. However, it is still
unclear how different PA intensities benefit this population. Most studies are limited to the
analysis of total PA, light intensity or intensities assessed by self-reports. Thus, this
systematic review sought to prospectively assess the association between MPA and moderatevigorous physical activity (MVPA), measured by accelerometer, with clinical and functional
outcomes related to health in individuals with COPD. Observational prospective cohort
studies with adults subjects (> 18 years), both sexes, diagnosed with COPD were included.
MPA or MVPA should be evaluated by accelerometer making associations with clinical and
functional outcomes. Outcomes were not considered as eligibility criteria, with all associated
outcomes reported in the review. Studies were identified through MEDLINE, EMBASE,
SPORTDiscus, and CINAHL database searches with no restrictions on publication date and
language. Reference lists of eligible studies were reviewed and a manual search for gray
literature was carried out to identify possibly eligible studies. Two reviewers carried out the
selection of studies, extraction of data and assessment of risk of bias and certainty of
evidence. When possible, meta-analysis was conducted using a random-effects model and
heterogeneity was measured by I2
statistic. When this was not possible, data were reported
descriptively. The risk of bias of the included studies was assessed using the Joanna Bridggs
Institute (JBI) Critical Appraisal Checklist instrument. The certainty of a body of evidence
was assessed by the Grading of Recommendations Assessment Development and Evaluation
(GRADE). Of the 22356 studies identified, five were included after removal of duplicates and
screening, covering 743 subjects with COPD. Moderate risk of bias was identified in most
studies, with a mean score of 5.6 out of 11. Very low certainty evidence showed a positive
association between MPA and lung function (r=0.20, 95%CI=0.08–0.31, p=0.0008, I2
=0%)
and quality of life (r=0.18, 95%CI=0.06–0.29, p=0.003, I2
=0%) in the long term. For studies
that were not possible to group, a positive association was found between MVPA and exercise
capacity (r=0.4085, 95%CI=0.3097 – 0.5073, p=0.000) and a negative association with
quality of life (r= -0.3228, 95%CI= -0.2165 – -0.4291, p= 0.0000) and dyspnea (r= -0.3392,
95%CI= -0.2344 – -0.444, p= 0.000) in the medium term. There were only descriptive data
available for mortality. Evidence suggests that MPA appears to be positively associated with
long-term lung function and quality of life. MVPA appears to be positively associated with
exercise capacity and negatively with quality of life and dyspnea in the medium term. More
studies are needed to gain confidence in these findings.
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

